NCT01958775View on ClinicalTrials.gov

Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Dyslipidemia
Interventions
DRUG

GLP-2

single subcutaneous dose of 1500mcg

DRUG

Placebo

Trial Locations (1)

M5G 1L7

Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01958775 - Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2 | Biotech Hunter | Biotech Hunter